Thrombosis Research
Volume 125 , Pages S52-S56 , April 2010

Alternatively spliced isoforms of tissue factor pathway inhibitor

  • Susan A. Maroney

      Affiliations

    • Blood Center of Wisconsin, Milwaukee, WI, USA
    • ,
  • Paul E. Ellery

      Affiliations

    • Blood Center of Wisconsin, Milwaukee, WI, USA
    • ,
  • Alan E. Mast

      Affiliations

    • Blood Center of Wisconsin, Milwaukee, WI, USA
    • Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA
    • Corresponding Author InformationCorresponding author. Blood Research Institute, Blood Center of Wisconsin, 8727 Watertown Plank Road, Milwaukee, WI 53226-3548, USA. Tel.: +1 414 937 6310; fax: +1 414 937 6284.

References 

  1. Carson SD. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor. FEBS Lett. 1981;132:37–40
  2. Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood. 1985;66:204–212
  3. Broze GJ, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci U S A. 1987;84:1886–1890
  4. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087–1097
  5. Engelmann B. Initiation of coagulation by tissue factor carriers in blood. Blood Cells Mol Dis. 2006;36:188–190
  6. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol. 1989;109:389–395
  7. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96:2311–2315
  8. Nossel HL, Yudelman I, Canfield RE, Butler VP, Spanondis K, Wilner GD, et al. Measurement of fibrinopeptide A in human blood. J Clin Invest. 1974;54:43–53
  9. Bauer KA, Kass BL, ten CH, Bednarek MA, Hawiger JJ, Rosenberg RD. Detection of factor X activation in humans. Blood. 1989;74:2007–2015
  10. Girard TJ, Eddy R, Wesselschmidt RL, MacPhail LA, Likert KM, Byers MG, et al. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. J Biol Chem. 1991;266:5036–5041
  11. Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterization of a cDNA coding for the lipoprotein- associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem. 1988;263:6001–6004
  12. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338:518–520
  13. Huang ZF, Broze G. Consequences of tissue factor pathway inhibitor gene-disruption in mice. Thromb Haemost. 1997;78:699–704
  14. Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood. 2005;105:2777–2782
  15. Westrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation. 2001;103:3044–3046
  16. Eitzman DT, Westrick RJ, Bi X, Manning SL, Wilkinson JE, Broze GJ, et al. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation. 2002;105:2139–2142
  17. Maroney SA, Cooley BC, Sood R, Weiler H, Mast AE. Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition. J Thromb Haemost. 2008;6:111–117
  18. Novotny WF, Girard TJ, Miletich JP, Broze GJ. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989;264:18832–18837
  19. Mast AE, Acharya N, Malecha MJ, Hall CL, Dietzen DJ. Characterization of the association of tissue factor pathway inhibitor with human placenta. Arterioscler Thromb Vasc Biol. 2002;22:2099–2104
  20. Broze GJ, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis. 1994;5:551–559
  21. Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinolysis. 1991;2:713–721
  22. Ott I, Andrassy M, Zieglgansberger D, Geith S, Schomig A, Neumann FJ. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood. 2001;97:3721–3726
  23. Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, Lupu C. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol. 2000;20:1362–1373
  24. Caplice NM, Mueske CS, Kleppe LS, Peterson TE, Broze GJ, Simari RD. Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res. 1998;83:1264–1270
  25. Pendurthi UR, Rao LV, Williams JT, Idell S. Regulation of tissue factor pathway inhibitor expression in smooth muscle cells. Blood. 1999;94:579–586
  26. Novotny WF, Girard TJ, Miletich JP, Broze GJ. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 1988;72:2020–2025
  27. Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 2007;109:1931–1937
  28. Maroney SA, Ferrel JP, Pan S, White TA, Simari RD, McVey JH, et al. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost. 2009;7:1106–1113
  29. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 1988;50:803–813
  30. Novotny WF, Palmier M, Wun TC, Broze GJ, Miletich JP. Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor. Blood. 1991;78:394–400
  31. Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor- dependent coagulation pathway. J Cell Biol. 1996;133:293–304
  32. Zhang J, Piro O, Lu L, Broze GJ. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation. 2003;108:623–627
  33. Chang JY, Monroe DM, Oliver JA, Roberts HR. TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene. Thromb Haemost. 1999;81:45–49
  34. Lockett JM, Mast AE. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor. Biochemistry. 2002;41:4989–4997
  35. Wesselschmidt R, Likert K, Girard T, Wun TC, Broze GJ. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood. 1992;79:2004–2010
  36. Chen HH, Vicente CP, He L, Tollefsen DM, Wun TC. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants. Blood. 2005;2004–2011
  37. Maroney SA, Ferrel JP, Collins ML, Mast AE. TFPIgamma is an active alternatively spliced form of TFPI present in mice but not in humans. J Thromb Haemost. 2008;6(8):1344–1351
  38. Maroney SA, Cunningham AC, Ferrel J, Hu R, Haberichter S, Mansbach CM, et al. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. J Thromb Haemost. 2006;4:1114–1124
  39. Piro O, Broze GJ. Comparison of cell-surface TFPIalpha and beta. J Thromb Haemost. 2005;3:2677–2683

PII: S0049-3848(10)00091-5

doi: 10.1016/j.thromres.2010.01.038

Thrombosis Research
Volume 125 , Pages S52-S56 , April 2010

Article Tools

* Image Usage & Resolution